These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38683568)

  • 1. Outcomes Following Localized Prostate Cancer Treatment.
    Huang TB; Ding XF
    JAMA; 2024 May; 331(20):1769. PubMed ID: 38683568
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
    Hoffman KE; Penson DF; Zhao Z; Huang LC; Conwill R; Laviana AA; Joyce DD; Luckenbaugh AN; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Koyama T; Barocas DA
    JAMA; 2020 Jan; 323(2):149-163. PubMed ID: 31935027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiandrogen therapy and side effects following radical prostatectomy.
    Clin J Oncol Nurs; 2000; 4(4):179-80. PubMed ID: 11261099
    [No Abstract]   [Full Text] [Related]  

  • 4. Measuring self-reported sexual function in men with prostate cancer.
    Brucker PS; Cella D
    Urology; 2003 Oct; 62(4):596-606. PubMed ID: 14550425
    [No Abstract]   [Full Text] [Related]  

  • 5. Local recurrence after primary therapy for clinically localized prostate cancer: is radiation or surgery "Better" in the salvage setting?
    Wood CG
    J Surg Oncol; 2008 Apr; 97(5):376. PubMed ID: 18360819
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer.
    Fu AZ; Tsai HT; Haque R; Ulcickas Yood M; Van Den Eeden SK; Cassidy-Bushrow AE; Zhou Y; Keating NL; Smith MR; Aaronson DS; Potosky AL
    World J Urol; 2016 Dec; 34(12):1611-1619. PubMed ID: 27084777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based study of long-term functional outcomes after prostate cancer treatment.
    Carlsson S; Drevin L; Loeb S; Widmark A; Lissbrant IF; Robinson D; Johansson E; Stattin P; Fransson P
    BJU Int; 2016 Jun; 117(6B):E36-45. PubMed ID: 25959859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and management of erectile dysfunction after various treatments for prostate cancer.
    Soh J; Kaiho Y; Kikuchi E; Oya M; Yoshioka K; Nakagami Y; Hatano T; Ozu C; Horiguchi Y; Namiki K; Tachibana M; Hisasue S; Tanaka N; Asakawa I
    Int J Urol; 2010 Aug; 17(8):689-97. PubMed ID: 20590940
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series.
    Fossati N; Karnes RJ; Boorjian SA; Moschini M; Morlacco A; Bossi A; Seisen T; Cozzarini C; Fiorino C; Noris Chiorda B; Gandaglia G; Dell'Oglio P; Joniau S; Tosco L; Shariat S; Goldner G; Hinkelbein W; Bartkowiak D; Haustermans K; Tombal B; Montorsi F; Van Poppel H; Wiegel T; Briganti A
    Eur Urol; 2017 Jun; 71(6):886-893. PubMed ID: 27484843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Androgen Deprivation Therapy and Salvage Radiotherapy versus Salvage Radiotherapy Alone for Recurrent Prostate Cancer after Radical Prostatectomy.
    Yoo S; You D; Kim YS; Hong JH; Ahn H; Kim CS
    Urol Int; 2017; 99(4):406-413. PubMed ID: 29020683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does one have a sexual life after prostate cancer treatment? ].
    Cosset JM
    Cancer Radiother; 2002 May; 6(3):183-7. PubMed ID: 12116844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential treatment for recurrent localized prostate cancer.
    Van Der Poel HG; Moonen L; Horenblas S
    J Surg Oncol; 2008 Apr; 97(5):377-82. PubMed ID: 18360820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage Local Treatments After Focal Therapy for Prostate Cancer.
    Marra G; Valerio M; Emberton M; Heidenreich A; Crook JM; Bossi A; Pisters LL
    Eur Urol Oncol; 2019 Sep; 2(5):526-538. PubMed ID: 31412013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized and Locally Advanced Prostate Cancer: Treatment Options.
    Achard V; Panje CM; Engeler D; Zilli T; Putora PM
    Oncology; 2021; 99(7):413-421. PubMed ID: 33784675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes and complications.
    Rosoff JS; Savage SJ; Prasad SM
    World J Urol; 2013 Dec; 31(6):1347-52. PubMed ID: 23358790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study.
    Mazariego CG; Egger S; King MT; Juraskova I; Woo H; Berry M; Armstrong BK; Smith DP
    BMJ; 2020 Oct; 371():m3503. PubMed ID: 33028540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer Patients.
    van Stam MA; Aaronson NK; Pos FJ; Bosch JL; Kieffer JM; Tillier CN; van der Poel HG
    Eur Urol; 2016 Nov; 70(5):751-757. PubMed ID: 27016464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An active sex life is possible for men undergoing androgen deprivation therapy for prostate cancer].
    Fode M; Østergren P; Jensen CF; Azawi N; Frey A; Sønksen J
    Ugeskr Laeger; 2015 Jun; 177(24):. PubMed ID: 26058525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates of primary and secondary treatments for patients on active surveillance for localized prostate cancer-A population-based cohort study.
    Matta R; Hird AE; Dvorani E; Saskin R; Nason GJ; Kulkarni G; Kodama RT; Herschorn S; Nam RK
    Cancer Med; 2020 Oct; 9(19):6946-6953. PubMed ID: 32757442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locally advanced prostate cancer: effective treatments, but many adverse effects.
    Prescrire Int; 2013 Jan; 22(134):18-20, 22-3. PubMed ID: 23367679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.